IPO News

Large potential IPOs are emerging across regions. In the US, Silvus considers a $5B valuation IPO, while Histosonics aims for a multi-billion dollar valuation. SailPoint eyes a $1B Nasdaq return. Europe sees EcoCeres planning a $5B IPO and HBX Group with strong book coverage for its Amsterdam listing.

US IPO market shows signs of heating up in early 2025 with notable confidential filings like Voyager Technologies in space and defense ($2-3B valuation). Odyssey Therapeutics (biotech), SailPoint (cybersecurity), and Metsera (obesity drugs) have also filed for IPOs on Nasdaq. While January saw a slow start, NYSE anticipates a robust IPO market recovery driven by a strong economy and potentially lower interest rates, suggesting a positive outlook for US listings in the coming months.

U.S. IPO activity is picking up with eToro's potential $5 billion+ and Klarna's possible $20 billion IPO. Titan America aims to raise over $500 million. In Asia, LG CNS priced its IPO at $823 million, and Guming Holdings targets $300 million in Hong Kong. Europe sees HBX Group's €725 million IPO. Riyad Capital's potential $2.5 billion IPO leads activity in MENA.

IPO activity is picking up globally, with the US seeing filings from biotech firms like Maze and Metsera. Europe anticipates large listings from Stada and HBX Group, while Shein and Shawbrook consider London. In Asia, NTT plans a Singapore REIT IPO, and several Chinese firms eye Hong Kong, though CATL's faces US blacklisting concerns. LG CNS launched its IPO in South Korea, while K Bank canceled its attempt. Saudi Tabreed is planning a potential Riyadh IPO.

EG Group, a UK-based fuel station operator, is planning a U.S. IPO valued at over $16 billion. Ascentage Pharma seeks $100 million in a Nasdaq IPO for cancer treatments. Germany's IPO market anticipates growth in 2025 with major listings. Chery Auto aims for a $1 billion Hong Kong IPO, valuing it at $14 billion. Meanwhile, Hong Kong will see 8 IPOs raising $755 million by mid-January 2025, reflecting robust investor interest.

In recent IPO news, the US market sees Databricks potentially delaying its IPO post-funding, while FedEx explores options for its freight division. Shifting focus internationally, there's positive momentum as EV battery giant CATL considers a significant Hong Kong listing. Adding to the upbeat news, Greek multinational METLEN is advancing its multi-billion pound London IPO, showcasing confidence in European markets.

London's IPO market shows mixed signals with French streaming firm Canal+ planning a €5-6 billion listing, while facing challenges with Shein's delayed approval over supply chain concerns. In Asia, Orion Breweries prepares for a $200 million Tokyo listing, Foshan Haitian seeks a HK$1.5 billion Hong Kong dual listing, and Kioxia completed an $800 million IPO, though at a valuation significantly below its 2018 level.

Recent IPO announcements reflect strong global market activity across diverse sectors. Notable listings include Holcim's $30 billion North American spin-off, Seven & i's $6.6 billion 7-Eleven USA IPO, and ServiceTitan's $5.16 billion tech listing in the U.S. The MENA region sees healthcare and retail offerings from Almoosa Health and Nice One, while Asia-Pacific activity includes Kioxia's $727 million Tokyo listing and Mao Geping's $270 million Hong Kong debut.

Global companies are preparing IPOs amid varied market conditions. In the U.S., ServiceTitan and CoreWeave plan significant offerings despite financial pressures. European firms like Apotea, Thyssenkrupp's Marine Systems, Odido, and Cirsa are set for listings. In Asia-Pacific, Insta360 and Mr DIY's Indonesian arm aim to go public. MENA's Talabat plans the UAE's largest IPO. Biotech firms Odyssey and Aktis proceed despite sector uncertainties, and Australia's Anteris files for a U.S. IPO.

Medline Industries plans a $5B U.S. IPO in 2025, potentially valuing the company at $50B. Pony AI seeks $260M in a U.S. IPO with Uber investing $10M. ServiceTitan files for Nasdaq listing, targeting SaaS growth. Canadian retailer Groupe Dynamite raises $300M. In Asia, Kioxia aims for $4.8B valuation, while Talabat targets $1.5B in Dubai. Australian DigiCo REIT launches a $1.8B IPO. UAE’s Pure Harvest eyes IPO by 2028.

Several companies are preparing IPOs globally. Highlights include Klarna's $20B U.S. IPO, Pony AI targeting a $4.48B Nasdaq valuation, and Venture Global LNG raising $3B. In Europe, VEON plans to list Kyivstar, and Carlyle considers a $4B IPO for Flender. Asia sees IPOs from Mokingran Jewellery, Dmall, and Adaro Energy, among others. Meanwhile, Middle Eastern IPOs feature Talabat’s $1B offering and UIHC's $264M debut. Key sectors include fintech, energy, transportation, and tech.

In 2025, notable upcoming IPOs include U.S. AI cloud provider CoreWeave with support from Morgan Stanley, and Canadian pharmaceutical firm Apotex. Europe's Studenac targets dual listings in Zagreb and Warsaw, while Asia sees Japan's Kioxia and Australia’s Cuscal filing. China’s CiDi and GoerTek plan Hong Kong IPOs, and MENA highlights UAE’s Lulu Retail on the ADX. Major expansions and sector-specific listings underscore a globally active IPO landscape.

Armis, a U.S.-based cybersecurity firm, secured $200 million in funding, elevating its valuation to $4.6 billion ahead of a 2026 IPO. South African retailer Pick n Pay plans the largest African IPO of the year by listing its discount chain, Boxer, aiming to raise $452 million to reduce debt. UAE's United International Holding Company seeks $265 million through an IPO on Tadawul to support United Electronics Company.

Maven Clinic, Chery Holding, and Brazil Potash Corp are each preparing for IPOs. Maven Clinic, a women’s telehealth service, appoints a new CFO for growth ahead of its planned U.S. IPO. China’s Chery Holding eyes a $14 billion Hong Kong IPO. Brazil Potash targets a $77 million U.S. IPO to support potash mining.

Global IPO activity is surging: Hyundai Motor India's $3.3 billion offering, the largest in India's history, achieved 18% subscription on day one. Oman's OQ Exploration raised a record $2.03 billion in the country's biggest IPO. UAE's Lulu Group plans a $1.8 billion IPO in Abu Dhabi. Tokyo Metro is setting up a significant listing in Japan. Horizon Robotics, backed by Alibaba and Baidu, launches a $696 million Hong Kong IPO. Pony.ai seeks $300 million in a U.S. IPO.

Honeywell plans to spin off its advanced materials division, generating $3.7-$3.9 billion in revenue, into a new public company by 2026. Cerebras Systems is likely to delay its IPO due to a CFIUS review over foreign investment. Tokyo Metro's $2.35 billion IPO is multiple times oversubscribed internationally and will begin trading on October 23, 2024. TenneT explores a spin-off or stake sale of its $21.95 billion German unit.

Several high-profile IPOs are set to debut across global markets. AI chipmaker Cerebras Systems plans a major Nasdaq listing, while Brazilian fintech PicPay and digital lender K Bank target significant offerings in 2025. In Europe, payments firm Ebury and sports supplements company Applied Nutrition prepare for London IPOs. Chinese AI firm Horizon Robotics seeks to raise $500 million in Hong Kong, and food delivery giant Talabat is eyeing a blockbuster Dubai listing with a potential valuation up to $15.1 billion.

Major upcoming IPOs include Titan America's expected $500 million raise in early 2025, potentially valuing it over $2 billion, and Spring Nature's anticipated IPO, possibly valuing the company at $10 billion by late 2024. In Asia, Midea Group raised $3.98 billion in Hong Kong's largest IPO in four years, while Enflame Technology aims to raise $280 million, targeting Shanghai's STAR board in late 2024.

Major upcoming IPOs include Titan America's expected $500 million raise in early 2025, potentially valuing it over $2 billion, and Spring Nature's anticipated IPO, possibly valuing the company at $10 billion by late 2024. In Asia, Midea Group raised $3.98 billion in Hong Kong's largest IPO in four years, while Enflame Technology aims to raise $280 million, targeting Shanghai's STAR board in late 2024.

Several major IPOs are expected, including Titan America’s $500 million U.S. listing, Samsonite’s dual U.S.-Hong Kong offering, and Midea Group’s $3 billion Hong Kong IPO, the largest in the region since 2021. Carlyle’s Acrotec Group could raise $4.7 billion in Zurich. Other notable deals include Delivery Hero’s Talabat listing in Dubai and Advanta Enterprises planning a $500 million IPO in India by 2025.

MBX Biosciences, specializing in GLP-1 drugs, has filed for a Nasdaq IPO. Delivery Hero plans to list its MENA unit, Talabat, in Dubai with a valuation of around $5.5 billion. Tembo E-LV will go public via a $904 million SPAC deal. Duality Biotherapeutics is preparing for a Hong Kong IPO, focusing on its ADC pipeline. NMDC Energy is launching an IPO in Abu Dhabi to raise $877 million.

Yanolja's Nasdaq IPO faces delays due to liquidity issues at its subsidiary, Qoo10, potentially impacting its financial health. Swiggy, India's food delivery giant, targets a $15 billion valuation in its upcoming IPO, one of the country's largest this year. Meanwhile, Japan's Kioxia Holdings plans a $500 million IPO, anticipated to be the largest in Japan since 2018.

WeRide delays Nasdaq debut while Samsonite eyes U.S. dual listing. European fintech giant Revolut secures $45B valuation, hinting at future IPO. Asian markets see flurry of activity with Airwallex targeting 2026 listing and 99 Speed Mart launching Malaysia's largest IPO in 7 years. Chinese firms explore Hong Kong listings despite market slowdown.

Abnormal Security raised $250M for IPO prep, aiming for a 2025 listing. China Resources Beverage received approval for a $1B Hong Kong IPO, while Honor, with state backing, eyes an A-share IPO. Continental revised spin-off plans, considering a Frankfurt listing for its automotive unit. Klarna explores a secondary share sale before a potential IPO. Egypt targets $2.5B from its government IPO program in FY2024/25.

In the U.S., AI chipmaker Cerebras Systems plans an October 2024 IPO, while Chinese firms YXT.com and WeRide file for Nasdaq listings. In Europe, the London Stock Exchange denies lowering standards for Shein's potential IPO. Asia sees activity with LG CNS preparing for a Seoul IPO, Zhongmiao Holdings pricing its Hong Kong offering, and Indian e-scooter maker Ola Electric setting terms for a major IPO, attracting global investors.

In the US, Medline Industries explores a $50 billion valuation IPO, while Google's acquisition talks with IPO candidate Wiz fell through. Europe sees Dolce&Gabbana considering an IPO and UK regulators easing capital raising rules. In Asia, Chinese companies like Midea and Hozon target Hong Kong and Southeast Asian markets for IPOs. The UAE's Pathfinder secures funding for a NASDAQ listing.

Chinese autonomous driving startup WeRide targets a $200M-$300M U.S. IPO, while Swedish fintech Klarna prepares for a potential 2025 listing. In Asia, several tech companies plan IPOs, including Manycore Tech in Hong Kong and i-Scream Media in South Korea. The Middle East sees increased IPO interest, with Abu Dhabi National Hotels and Saudi Arabia's sovereign wealth fund planning listings. Meanwhile, U.S.-based 401(k) provider Human Interest raises $267M, eyeing a future IPO.

Global IPO activity is showing signs of revival, with notable announcements across the US, Europe, and Asia-Pacific regions. Companies like TWFG Insurance, Smithfield Foods, and Hyundai's Indian subsidiary are planning significant IPOs. The UK is implementing major listing rule changes to attract more issuers. China is experiencing an IPO retreat due to stricter standards, while other Asian markets, including Thailand and Hong Kong, are seeing increased IPO interest.

The global IPO market shows strong activity across regions. In the U.S., companies like Actuate Therapeutics and OneStream are pursuing significant IPOs. Europe sees both launches and postponements, with firms like Revolut considering venues. Asia-Pacific, particularly South Korea, experiences record-breaking investor interest. The MENA region, especially Gulf markets, demonstrates a robust IPO pipeline. Sectors such as technology, healthcare, and financial services dominate the listings, reflecting investor appetite for growth industries.

In the U.S., companies like Ardent Health, Hailo, Solera, and Lineage are pursuing significant IPOs. Asia-Pacific sees strong momentum, with firms like Duality Biologics, Kioxia, Momenta, and Hozon filing for IPOs. The region is expected to be a hot spot for equity deals in H2 2024, particularly in India. In the MENA region, Saudi Arabia's Fourth Milling Company plans to list a 30% stake, aligning with the country's Vision 2030 strategy.